The euthanasia ad which will not be shown in Australia
Nitschke fails to get approval
A pro-euthanasia television advertisement
commissioned by Australian activist Dr Philip Nitschke was pulled two days
before it was due to go to air because the commercial TV industry feared it would
breach broadcast regulations.
The Commercial Television Industry Code of
Practice states “material that will invariably be unsuitable for television”
includes “Suicide: Realistic depiction of methods of suicide, or promotion or
encouragement of suicide.”
Dr Nitschke argues that the advertisement
does not promote suicide. “It shows a person that is simply reflecting on
the fact he’s had choices all his life and now the important choice is
effectively denied him,” he said. “He says he’s made his choice, he
just wants the Government to listen so it doesn’t give any specifics about how
a person could end their life.”
Dr Nitschke has also commissioned
pro-euthanasia billboards but these are now under
threat as well. ~ ABC, Sept 13;
Mumbrella, Sept 12;
Michael Cook
euthanasia
YouTube
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...